Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Mr. Stephen La Neve 2025 'den beri şirketle birlikte olan Accuray Inc 'in President 'ıdır.
ARAY hissesinin fiyat performansı nasıl?
ARAY 'in mevcut fiyatı $0.392 'dir, son işlem günde 1.52% arttırılmış etti.
Accuray Inc için ana iş temaları veya sektörler nelerdir?
Accuray Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Accuray Inc 'in piyasa değerlemesi nedir?
Accuray Inc 'in mevcut piyasa değerlemesi $46.5M 'dir
Accuray Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 4 analist Accuray Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 4 güçlü al, 3 al, 1 tut, 0 sat ve 4 güçlü sat içermektedir